Skip to main content

OSU, OU collaboration finds semaglutide treatment associated with reductions in alcohol use disorder symptoms

The first published evidence from humans that semaglutide specifically reduces the symptoms of Alcohol Use Disorder (AUD) has been published in The Journal of Clinical Psychiatry and details a recent collaboration between clinicians and scientists at the OU-TU School of Community Medicine and OSU Center for Health Sciences.
Dr. Kyle Simmons (left), Ph.D., and OSU-CHS professor of pharmacology and physiology, and Dr. Jesse Richards, assistant professor of medicine at OU-TU School of Community Medicine, discuss their research collaboration studying how semiglutide may be used to treat alcohol use disorder at the Hardesty Center for Clinical Research and Neuroscience in Tulsa.
Hardesty Family Foundation donates $2 million to OSU for creation of new research center in Tulsa

Mon, Oct 26, 2020

With a $2 million gift, The Hardesty Family Foundation has made a commitment to fuel transformative research at the National Center for Wellness & Recovery. In recognition of the contribution, OSU is naming a recently acquired 49,000-square-foot medical complex in south Tulsa the Hardesty Center for Clinical Research and Neuroscience.

OSU FoundationCampus Life and DiversityOSU medicineNational Center for Wellness & RecoveryResearchOSU Center for Health SciencesHardesty Family FoundationCenter for Health SciencesHardesty Center for Clinical Research and NeuroscienceHuman Health and WellnessOutreach and Engagement

Back To Top